Despite efforts for improvement, the "State of the Air" report reveals concerns.

Published Date: 23 Apr 2023

Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.

Read Full News

Latest News

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Latest News

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Health news and commentary gathered by MedPage Today staff

States warned residents about air quality issues that could last for days

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

News All Time

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Why Is a Fit Swimmer Breathless and Coughing Up Blood?

Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers

Psychosis and Cannabis Legalization: Where's the Evidence?

As marijuana policy shifts nationwide, researchers are tracking possible link to psychosis

FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market

It's highly unusual for the FDA to draft new policies without input from the staffers

Chronic Sinus Inflammation Linked to Roadway Gases

Gaseous pollutants from traffic sources add to evidence for particulate-matter harms

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 insertions

Drug Combo for Lung Cancer Beats Pembrolizumab in First-Line Trial

Antibody-drug conjugate plus pembrolizumab superior to pembrolizumab alone in PD-L1 expressors

'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting

Substantial EFS improvement with selpercatinib in RET fusion-positive disease

Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC

HARMONi-6 showed 34% drop in death risk, but trial had an all-Asian population, expert warned

U.S. Adult Cigarette Smoking Rate Hits Another All-Time Low

Use of electronic cigarettes has been inching up, but has held about steady in 2025

'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist

Primary endpoints met in knee osteoarthritis and obstructive sleep apnea, too

Recommended News For You

FDA Panel Endorses Capivasertib Use in Prostate Cancer

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Similar survival seen with simple versus radical hysterectomy for cervical cancer

Waiting for a Sharp Increase in Prostate Cancer Cases.

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

Recommended Articles For You

Clinical Guidelines for Hematopoietic Stem Cell Niche Monitoring in Blood Disorders 

Breaking Barriers: Innovative Approaches in Brain Tumor Treatment 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Innate Lymphoid Cells in Tumor Biology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

2.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

3.

Are patients with advanced cancer receiving treatment aligned with their goals?

4.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

5.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

1.

Red Cell Adaptation During Female Reproductive Transitions: Mechanisms, Clinical Implications, and Evidence-Based Insights

2.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

3.

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

4.

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management

5.

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part I

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot